Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03180086 · ClinicalTrials.gov registry record · NA
Breast Cancer Risk Assessment in Women Aged 40-49
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT03180086 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 338 participants.
The verdict
NCT03180086, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
In a randomized controlled trial, the investigators will test the effect of a novel strategy for breast cancer risk assessment and risk-based management of women in their 40s seen in primary care. The investigators anticipate that this approach will lead to more optimal use of mammography screening and breast cancer prevention interventions in women in their 40s and as a result will improve care of these women.
Interventions
- OTHER Breast cancer risk report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2019-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03180086
The ClinicalTrials.gov registry entry for NCT03180086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast cancer risk report is the first listed.
NCT03180086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03180086 about?
NCT03180086 is a clinical study titled "Breast Cancer Risk Assessment in Women Aged 40-49". In a randomized controlled trial, the investigators will test the effect of a novel strategy for breast cancer risk assessment and risk-based management of women in their 40s seen in primary care. The investigators anticipate that this approach will lead to more optimal use of mammography screening ...
What is the current status of trial NCT03180086?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2017-07-01. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT03180086?
The interventions under investigation include: Breast cancer risk report (OTHER).
Who is sponsoring clinical trial NCT03180086?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.